Neurogesx's Series A Round

Neurogesx raised a round of funding on June 15, 2000.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neura…

Articles about Neurogesx's Series A Round: